Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Janssen Biotech receives complete response letter for sirukumab BLA

Sep. 26, 2017

ImmuPharma offers update on Lupuzor program

Sep. 26, 2017

NIH grant to support development of Cel-Sci's rheumatoid arthritis vaccine

Sep. 20, 2017

Boehringer Ingelheim receives positive opinion for adalimumab biosimilar Cyltezo

Sep. 18, 2017

Phase III trial of upadacitinib in rheumatoid arthritis meets all endpoints

Sep. 12, 2017

Daiichi Sankyo and Sanford Burnham Prebys begin clinical trial of DS-1211

Sep. 7, 2017

Promising RORgammaT inhibitors discovered at Merck & Co.

Sep. 5, 2017

EMD Serono details discovery of BTK inhibitor now in clinical development

Sep. 4, 2017

Phase II trial explores use of MBS-2320 in active rheumatoid arthritis

Aug. 31, 2017

European Commission approves adalimumab biosimilar Imraldi

Aug. 25, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...